Valbiotis: Information on Share Capital and Voting Rights

As of May 31, 2025, Valbiotis published its monthly report on share capital and voting rights. The company, listed on Euronext Growth Paris, revealed a total of 15,910,365 shares comprising the share capital. The total number of theoretical voting rights amounts to 16,615,083, while exercisable voting rights amount to 16,581,719, after taking into account treasury shares.

In accordance with Article 10.5 of Valbiotis's bylaws, any transaction resulting in the holding of at least 5% of the capital must be reported to the company, failing which voting rights for undeclared shares will be lost. Transparency in the communication of this information is crucial for investors and shareholders.